StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$96.43+2.52 (+2.68%)

Close on Nov 18, 2026Market cap $3.34BP/E 25.0Yield 0.00%

TransMedics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

TransMedics's operating income for the twelve months ending Jun 30, 2026 was $81.61M, up 6.6% year over year. For fiscal 2025 it was $108.58M, up 189.6% from the year before. The highest annual figure on record is $108.58M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$108.58M+189.6%
FY2024Dec 31, 2024$37.50M–
FY2023Dec 31, 2023-$28.73M–
FY2022Dec 31, 2022-$31.44M–
FY2021Dec 31, 2021-$39.43M–
FY2020Dec 31, 2020-$26.38M–
FY2019Dec 28, 2019-$29.60M–
FY2018Dec 29, 2018-$20.24M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$23.74M-35.1%
Q1 FY2026Mar 31, 2026$13.30M-51.5%
Q4 FY2025Dec 31, 2025$21.27M+146.1%
Q3 FY2025Sep 30, 2025$23.30M+493.9%
Q2 FY2025Jun 30, 2025$36.57M+192.3%
Q1 FY2025Mar 31, 2025$27.44M+120.9%
Q4 FY2024Dec 31, 2024$8.64M+232.1%
Q3 FY2024Sep 30, 2024$3.92M–
Q2 FY2024Jun 30, 2024$12.51M–
Q1 FY2024Mar 31, 2024$12.42M–
Q4 FY2023Dec 31, 2023$2.60M–
Q3 FY2023Sep 30, 2023-$28.34M–
Q2 FY2023Jun 30, 2023-$906.00K–
Q1 FY2023Mar 31, 2023-$2.09M–
Q4 FY2022Dec 31, 2022-$6.78M–
Q3 FY2022Sep 30, 2022-$5.54M–
Q2 FY2022Jun 30, 2022-$9.75M–
Q1 FY2022Mar 31, 2022-$9.37M–
Q4 FY2021Dec 31, 2021-$11.33M–
Q3 FY2021Sep 30, 2021-$11.73M–
Q2 FY2021Jun 30, 2021-$9.87M–
Q1 FY2021Mar 31, 2021-$6.51M–
Q4 FY2020Dec 31, 2020-$5.90M–
Q3 FY2020Sep 30, 2020-$4.61M–
Q2 FY2020Jun 30, 2020-$7.86M–
Q1 FY2020Mar 31, 2020-$8.02M–
Q4 FY2019Dec 28, 2019-$8.69M–
Q3 FY2019Sep 28, 2019-$7.24M–
Q2 FY2019Jun 29, 2019-$7.71M–
Q1 FY2019Mar 30, 2019-$5.96M–
Q4 FY2018Dec 29, 2018-$6.36M–
Q3 FY2018Sep 29, 2018-$3.94M–
Q2 FY2018Jun 30, 2018-$5.16M–
Q1 FY2018Mar 31, 2018-$4.78M–

More TransMedics figures

See a number that looks wrong?